Homepage
Medication Guide
Dosage and Administration of Encorafenib (Braftovi)
Encorafenib (Braftovi) is a kinase inhibitor indicated for use in combination with specific drugs to treat unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations, metastatic color...
510
Wednesday, January 21st, 2026, 09:15
What Are the Indications for Encorafenib (Braftovi)?
Encorafenib (Braftovi) is an oral targeted therapy that belongs to the class of kinase inhibitors. It is primarily used in combination with specific regimens for the treatment of advanced cancers harb...
514
Wednesday, January 21st, 2026, 09:10
What Are the Procurement Channels for Encorafenib (Braftovi)?
Encorafenib (Braftovi) is a targeted therapy indicated for the treatment of cancers with specific gene mutations, such as melanoma, colorectal cancer, and non-small cell lung cancer. As a prescription...
508
Tuesday, January 20th, 2026, 09:52
Adverse Effects of Canakinumab (Ilaris)
Canakinumab (Ilaris) is a monoclonal antibody drug indicated for the treatment of various autoinflammatory diseases, exerting its therapeutic effects by inhibiting interleukin-1β (IL-1β). Despite its ...
508
Tuesday, January 20th, 2026, 09:49
What are the Precautions for Canakinumab (Ilaris) Administration?
Canakinumab (Ilaris) is a humanized monoclonal antibody that exerts its therapeutic effect by specifically blocking the activity of interleukin-1β (IL-1β), and is primarily indicated for the treatment...
513
Tuesday, January 20th, 2026, 09:47
Dosage and Administration, Recommended Doses of Canakinumab (Ilaris)
Canakinumab (Ilaris) is a fully human monoclonal antibody that neutralizes interleukin-1β (IL-1β) with high affinity and selectivity, thereby inhibiting its key role in various autoinflammatory diseas...
510
Tuesday, January 20th, 2026, 09:45
What are the Indications for Canakinumab (Ilaris)?
Canakinumab (Ilaris) is a recombinant humanized monoclonal antibody indicated for the treatment of various autoinflammatory diseases. It exerts its therapeutic effect by specifically neutralizing the ...
514
Tuesday, January 20th, 2026, 09:42
What Are the Purchase Channels for Canakinumab (Ilaris)?
Canakinumab (Ilaris) is a biological agent indicated for the treatment of various inflammatory diseases. Its purchase channels and precautions are of great significance for patients.What Are the Purch...
516
Monday, January 19th, 2026, 14:47
Adverse Reactions of Trabectedin (Yondelis)
Trabectedin (Yondelis) is an alkylating agent indicated for the treatment of unresectable or metastatic liposarcoma or leiomyosarcoma in patients who have received prior anthracycline-containing regim...
508
Monday, January 19th, 2026, 14:44
What are the Precautions for Using Trabectedin (Yondelis)?
Trabectedin (Yondelis) is an alkylating antineoplastic agent indicated for the treatment of specific soft tissue sarcomas. It is used in patients with unresectable or metastatic liposarcoma or leiomyo...
512
Monday, January 19th, 2026, 14:27
28 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved